Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking approach to diabetes management. These innovative drugs work by mimicking the physiological actions of GLP-1, a hormone produced by the gut https://minanjzv394011.blog2news.com/39574003/reta-glucagon-like-peptide-1-receptor-agonists